# Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial

> **NCT05932472** · PHASE4 · RECRUITING · sponsor: **Tor Biering-Sørensen** · enrollment: 32706 (estimated)

## Conditions studied

- Atherosclerosis
- Cardiovascular Diseases
- Drug Effect

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT05932472
- **Lead sponsor:** Tor Biering-Sørensen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-15
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-02-15
- **Target enrollment:** 32706 (ESTIMATED)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932472, "Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05932472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*